Fensolvi — Medica
Gender-dysphoric/gender-incongruent persons; persons undergoing gender reassignment (female-to-male or male-to-female)
Initial criteria
- Prescribed by, or in consultation with, an endocrinologist or a physician who specializes in the treatment of transgender patients
Approval duration
1 year